Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose target-controlled naloxone infusion pharmacokinetics
2015-000815-42Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of naloxone, sponsored by Rigshospitalet. Primary endpoint: Standard pharmacokinetic parameters of naloxone and main metabolites. Started Mar 2015; status: completed.
02
Drugs
naloxone
Beyond the preview
Go deeper on 2015-000815-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000815-42.